From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study
Terlipressin group (n = 50)
Placebo group (n = 50)
P value
CPB time (min)
109.0 ± 34.1
115.1 ± 37.4
0.39
AoX time (min)
38.1 ± 9.6
41.0 ± 8.4
0.10
No. of grafts
3.2 ± 0.8
3.4 ± 0.8
0.32
Hypothermia (° C)
32.8 ± 0.8
33.1 ± 0.9
0.17